Bad law or implementation flaws? Lessons from the implementation of the new law on epidemics during the response to the first wave of COVID-19 in Switzerland나쁜 법률 또는 구현 결함? 스위스 COVID-19의 첫 번째 물결에 대응하는 동안 전염병에 관한 새로운 법률 시행에서 얻은 교훈Article Published on 2021-10-012022-09-11 Journal: Health policy (Amsterdam, Netherlands) [Category] SARS, 신종인플루엔자, 치료기술, [키워드] applied COVID-19 COVID-19 pandemic delayed response disease outbreak Diseases Early detection Epicentre Epidemics Europe excluded First wave force H1N1 H1N1 pandemic implementation Infectious diseases International international cooperation introduced involved Italian lesson lombardy management mechanism outbreak pandemic pharmaceutical industry problem Public public health referendum reform Spread Surveillance survived Switzerland tension Vaccine [DOI] 10.1016/j.healthpol.2021.08.004 PMC 바로가기 [Article Type] Article
Discovery, Development, and Patent Trends on Molnupiravir: A Prospective Oral Treatment for COVID-19Molnupiravir에 대한 발견, 개발 및 특허 동향: COVID-19에 대한 유망한 경구 치료제Review Published on 2021-09-242022-09-10 Journal: Molecules [Category] SARS, 임상, 치료제, [키워드] Baricitinib Clinical data clinical trial Combination COVID-19 COVID-19 pandemic demonstrated develop development disease dosage drug effective EIDD-1931 EIDD-2801 Favipiravir forms humans Influenza inhalers market meet MK-4482 molnupiravir oral oral bioavailability pandemic Patent patents Patient pharmaceutical industry Phase 3 phase 3 clinical trial present Prospective RdRP RdRp inhibitor Remdesivir researcher Safe safety profile SARS-CoV-2 Tolerability tolerable treat Treatment treatment of influenza treatments for COVID-19 trend university USA variety viruses [DOI] 10.3390/molecules26195795 PMC 바로가기 [Article Type] Review
Metal-Promoted Heterocyclization: A Heterosynthetic Approach to Face a Pandemic Crisis금속 촉진 이형 고리화: 팬데믹 위기에 직면하기 위한 이형 합성 접근법Review Published on 2021-04-292022-09-10 Journal: Molecules [Category] MERS, SARS, 치료제, [키워드] administration Anti-inflammatory anticancer Antiviral approved drugs battle Bioactivity can not changed construction coronavirus crisis drug drugs targeting effective response everyday life face focus heterocyclization life metal-promoted mitigate outbreak pharmaceutical industry pharmacological plethora SARS-CoV-2 SARS-CoV-2 coronavirus Scientific community skeleton starting point Vaccine virus [DOI] 10.3390/molecules26092620 PMC 바로가기 [Article Type] Review
French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 PandemicCOVID-19 팬데믹 기간 동안 임상 연구에 대한 프랑스 대중의 친숙도와 태도Article Published on 2021-03-052022-09-10 Journal: International Journal of Environmental Research an [Category] SARS, 임상, [키워드] Attitude claimed Clinical research clinical trial clinical trials conducted COVID-19 COVID-19 pandemic crisis management Drawing familiarity France French indicated information literacy management media media coverage Odds ratio pandemic Pandemics pharmaceutical industry positive attitude preparation proportion provided Public public attitudes Ratio Research side survey Vaccine development while [DOI] 10.3390/ijerph18052611 PMC 바로가기 [Article Type] Article
Phytochemicals against SARS-CoV as potential drug leads잠재적 약물 리드로서 SARS-CoV에 대한 파이토케미컬Article Published on 2021-03-012022-09-11 Journal: Biomedical journal [Category] SARS, 신약개발, [키워드] accelerate against SARS-CoV Analysis analyzed antiinflammatory antimalarial drug Antimalarial drugs Antiviral antiviral drug antiviral drugs assays cellular Cluster cluster analysis coronavirus CoV cysteine derivatives develop Developing drug Drug development drugs followed by health emergency Herbal herbal medicine in vitro information Lopinavir LOPINAVIR AND RITONAVIR MERS molecular docking natural natural products Pandemics pharmaceutical industry phytochemical protease reported researcher Ritonavir Safe SARS-CoV-2 SARS-CoV-2 strain Scientific community selected strain systematic review target [DOI] 10.1016/j.bj.2020.12.002 PMC 바로가기 [Article Type] Article
New Approaches to Regulatory Innovation Emerging During the Crucible of COVID-19 : In Responding to a Global Health Crisis, Industry is Discovering New, Efficient Ways of Meeting ObjectivesCOVID-19의 도가니 중에 등장하는 규제 혁신에 대한 새로운 접근 방식: 세계 보건 위기에 대응하기 위해 업계는 목표를 달성하는 새롭고 효율적인 방법을 발견하고 있습니다Article Published on 2021-03-012022-08-31 Journal: Therapeutic innovation & regulatory science [Category] 신약개발, [키워드] addition Affair agency agility Bayer benefit Caregivers Clinicians Cloud-based systems coronavirus Coronavirus pandemic COVID-19 COVID-19 crisis COVID-19 pandemic crisis Crucible Decentralized trials develop efficient Evidence exhibited flexible global health Guidance head Impact IMPROVE Innovation medical need Medicines meeting New objective pandemic Patient patients pharmaceutical pharmaceutical industry platform provided Regulation Regulatory regulatory agencies regulatory agency Regulatory policy remote Remote work. Responding speed Therapies therapy trials urgency Vaccines virus [DOI] 10.1007/s43441-020-00239-8 PMC 바로가기 [Article Type] Article
Repurposing drugs during the COVID-19 pandemic and beyondCOVID-19 대유행 기간 동안 및 그 이후에 약물 용도 변경Review Published on 2021-01-152022-08-31 Journal: Pharmaceutical Patent Analyst [Category] 신약개발, 치료제, [키워드] COVID-19 pandemic drug pandemic patent claims pharmaceutical industry repurposing [DOI] 10.4155/ppa-2020-0031 PMC 바로가기 [Article Type] Review
COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assaysCOVID-19 약물 용도 변경: 컴퓨터 스크리닝 방법, 임상 시험 및 단백질 상호 작용 분석에 대한 검토Review Published on 2021-01-012022-08-31 Journal: Medicinal research reviews [Category] 신약개발, 임상, [키워드] clinical trial clinical trials Clinicians computational research coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 treatment creation drug drug combinations Drug development Drug discovery Drug repurposing effective Efficacy experiments facilitate globe groups in vitro in vitro protein interaction assay. information Interaction mechanism organized pandemic pharmaceutical industry Protein Providing Research researcher screening methods situation the disease therapeutic Treatment [DOI] 10.1002/med.21728 PMC 바로가기 [Article Type] Review
Manufacturing and Management of CAR T-Cell Therapy in “COVID-19’s Time”: Central Versus Point of Care Proposals"COVID-19 시대"의 CAR T-세포 치료제 제조 및 관리: 중앙 대 진료 현장 제안Review Published on 2020-10-152022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 바이오마커, 진단, [키워드] administration adoptive cell immunotherapy affected antigen receptor attenuate CAR caused Cell cell therapies chimeric antigen receptor COVID-19 pandemic criteria curative treatment cytokine Cytokine release syndrome focus good manufacturing practice Health Service Health services hematologic hospital hospitalized patients Infection Intervention malignancies manufacturing process neurotoxicity Patient patient selection pharmaceutical industry Point Prevent Prophylactic reduction resource respiratory Safe SARS-CoV-2 SARS-CoV-2 coronavirus saturation Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 supply chains T-cell T-cells Therapies therapy Tocilizumab Treatment [DOI] 10.3389/fimmu.2020.573179 PMC 바로가기 [Article Type] Review
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?Opinion Article Published on 2020-04-012022-10-31 Journal: F1000Research [Category] Coronavirus, MERS, SARS, [키워드] active pharmaceutical ingredients assist COVID-19 COVID-19 pandemic Critical diagnostic generic drugs healthcare help India maintaining manufacturing industry medicine access Medicines outbreak pharmaceutical industry Preventing reducing regulatory agency therapeutic urgency Vaccine while [DOI] 10.12688/f1000research.23057.1 PMC 바로가기 [Article Type] Opinion Article